Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

BingX Reaches No.1 in TradFi Perpetual Assets Coverage with 500+ Listings

August 26, 2026

Investigation underway after 18-year-old struck by GO train in Toronto’s east end

August 26, 2026

Carney will address the European Parliament next month

August 26, 2026

Prince Harry and Meghan Markle return to the U.K.

August 26, 2026

What Makes a Great Seafood Restaurant in Hallandale Beach?

August 26, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Scene Health Appoints Lisa Ritsky-Lamb as Chief Financial Officer to Accelerate Next Phase of Growth
Press Release

Scene Health Appoints Lisa Ritsky-Lamb as Chief Financial Officer to Accelerate Next Phase of Growth

By News RoomAugust 26, 20263 Mins Read
Scene Health Appoints Lisa Ritsky-Lamb as Chief Financial Officer to Accelerate Next Phase of Growth
Share
Facebook Twitter LinkedIn Pinterest Email

Lisa Ritsky-Lamb

Scene Health Appoints Lisa Ritsky-Lamb as Chief Financial Officer

BALTIMORE, Aug. 26, 2026 (GLOBE NEWSWIRE) — Scene Health, a leader in MedEngagement, today announced the appointment of Lisa Ritsky-Lamb as Chief Financial Officer (CFO). Ritsky-Lamb joins the executive leadership team as Scene Health continues to expand its impact to support true medication adherence: helping people take their medication as prescribed, every day. Medication non-adherence continues to pose a significant challenge, with the U.S. healthcare system incurring over $500 billion annually in preventable hospitalizations due to this issue. Ritsky-Lamb will lead the company’s finance organization and play a pivotal role in driving the company’s next phase of strategic growth.

With more than 25 years of executive finance leadership experience across healthcare, SaaS, and technology, Ritsky-Lamb brings deep expertise in financial strategy, forecasting, mergers and acquisitions, and building high-performing finance organizations. She will partner across the organization to support Scene Health’s continued growth, operational excellence, and long-term value creation.

“I’m thrilled to join Scene Health and a team that is tackling such an important and costly challenge in healthcare,” said Ritsky-Lamb. “Scene Health has built a differentiated approach to improving medication adherence and a compelling opportunity to make a meaningful impact across healthcare. I’m looking forward to partnering with the team to build on that momentum, scale the business thoughtfully, and translate Scene Health’s strong clinical impact into sustainable growth and long-term value.”

Before joining Scene Health, Ritsky-Lamb served as Chief Financial Officer at Mytonomy, where she led the finance organization through the company’s successful acquisition by Elsevier. She previously held executive finance leadership roles at Omnicell, Thermo Fisher Scientific, and Cardinal Health, partnering across product, commercial, operations, and engineering organizations to improve profitability, scale high-growth businesses, and enable data-driven strategic decision-making.

”Lisa Ritsky-Lamb is the right finance leader at the right time for Scene Health. Her rich experience in leading finance across diverse healthcare organizations is a competitive advantage for the company as we scale our MedEngagement program in this phase of rapid growth.”

Scene Health is the industry leader in MedEngagement, a care model pioneered by Scene Health to move beyond traditional medication adherence using technology, human support, and validated interventions—including the gold standard, directly observed therapy. For more than a decade, Scene Health has partnered with public health departments, Medicaid and Medicare MCOs, and life science organizations across the U.S. to dramatically improve adherence rates, cost of care, and health outcomes for a wide range of diseases. For more information, contact [email protected] 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/29136170-89c4-4cf4-a18b-8fac3ccae493

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

BingX Reaches No.1 in TradFi Perpetual Assets Coverage with 500+ Listings

What Makes a Great Seafood Restaurant in Hallandale Beach?

PURE HomeRiver Deepens Its Commitment to AppFolio to Power the Next Phase of Its Growth

SYVIC Opens Public Sign-Up for U.S. Civic-Tech Initiative Exploring AI and Public Representation

CrowdMatch Opens Public Waitlist for Dating App Where the Crowd Does the Matching

SHEIN Canada Launches Campus Ambassador Program, Kicking Off with a Back-to-School Activation with the Toronto Metropolitan Students’ Union

INE Launches eIAMA Certification to Help Organizations Build Practical Identity and Access Management Skills

MotorWeek celebrates 46 seasons of maximizing your automotive dollar

Fellow's New Governance Suite Brings Compliance-Grade Controls to AI Meeting Notes

Editors Picks

Investigation underway after 18-year-old struck by GO train in Toronto’s east end

August 26, 2026

Carney will address the European Parliament next month

August 26, 2026

Prince Harry and Meghan Markle return to the U.K.

August 26, 2026

What Makes a Great Seafood Restaurant in Hallandale Beach?

August 26, 2026

Latest News

Apple announces September iPhone launch event

August 26, 2026

PURE HomeRiver Deepens Its Commitment to AppFolio to Power the Next Phase of Its Growth

August 26, 2026

SYVIC Opens Public Sign-Up for U.S. Civic-Tech Initiative Exploring AI and Public Representation

August 26, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version